EAPIF
Price
$3.09
Change
-$0.56 (-15.34%)
Updated
Aug 6 closing price
Capitalization
325.72M
HLNCF
Price
$4.87
Change
-$0.03 (-0.61%)
Updated
Sep 5 closing price
Capitalization
44.18B
Interact to see
Advertisement

EAPIF vs HLNCF

Header iconEAPIF vs HLNCF Comparison
Open Charts EAPIF vs HLNCFBanner chart's image
EUROAPI SA
Price$3.09
Change-$0.56 (-15.34%)
Volume$292
Capitalization325.72M
HALEON
Price$4.87
Change-$0.03 (-0.61%)
Volume$1.58K
Capitalization44.18B
EAPIF vs HLNCF Comparison Chart in %
Loading...
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EAPIF vs. HLNCF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAPIF is a Hold and HLNCF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (EAPIF: $3.09 vs. HLNCF: $4.87)
Brand notoriety: EAPIF and HLNCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EAPIF: 25% vs. HLNCF: 10%
Market capitalization -- EAPIF: $325.72M vs. HLNCF: $44.18B
EAPIF [@Pharmaceuticals: Generic] is valued at $325.72M. HLNCF’s [@Pharmaceuticals: Generic] market capitalization is $44.18B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EAPIF’s FA Score shows that 0 FA rating(s) are green whileHLNCF’s FA Score has 1 green FA rating(s).

  • EAPIF’s FA Score: 0 green, 5 red.
  • HLNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both EAPIF and HLNCF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EAPIF’s TA Score shows that 2 TA indicator(s) are bullish while HLNCF’s TA Score has 3 bullish TA indicator(s).

  • EAPIF’s TA Score: 2 bullish, 2 bearish.
  • HLNCF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EAPIF is a better buy in the short-term than HLNCF.

Price Growth

EAPIF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HLNCF (@Pharmaceuticals: Generic) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLNCF($44.2B) has a higher market cap than EAPIF($326M). HLNCF has higher P/E ratio than EAPIF: HLNCF (21.70) vs EAPIF (7.92). HLNCF YTD gains are higher at: 4.060 vs. EAPIF (2.890). HLNCF has higher annual earnings (EBITDA): 2.71B vs. EAPIF (-34.7M). HLNCF has more cash in the bank: 676M vs. EAPIF (73M). EAPIF has less debt than HLNCF: EAPIF (69.1M) vs HLNCF (8.45B). HLNCF has higher revenues than EAPIF: HLNCF (11B) vs EAPIF (919M).
EAPIFHLNCFEAPIF / HLNCF
Capitalization326M44.2B1%
EBITDA-34.7M2.71B-1%
Gain YTD2.8904.06071%
P/E Ratio7.9221.7036%
Revenue919M11B8%
Total Cash73M676M11%
Total Debt69.1M8.45B1%
TECHNICAL ANALYSIS
Technical Analysis
EAPIFHLNCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
35%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
22%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
58%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
31%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IUENX29.03N/A
N/A
JPMorgan International Focus R6
GCIFX15.30N/A
N/A
Green Century MSCI Intl Indx Instl
PRJBX46.67N/A
N/A
PGIM Jennison Global Opportunities R2
BUITX24.01N/A
N/A
Buffalo Mid Cap Discovery Inst
CGLIX18.24N/A
N/A
Calvert Global Equity Fund Class I

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
-0.41%
HLNCF - EAPIF
11%
Poorly correlated
-0.61%
IXHL - EAPIF
7%
Poorly correlated
-9.48%
STEK - EAPIF
6%
Poorly correlated
-3.45%
AKAN - EAPIF
2%
Poorly correlated
-2.54%
More